The use of a systemic therapy checklist improves the quality of data acquisition and recording in multicentre trials. A study of the EORTC Soft Tissue and Bone Sarcoma Group

European Journal of Cancer Part A

Volumn 33, Issue 7, 1997, Pages 1045-1049

  Verweij, J ^a   Nielsen, O S ^b   Therasse, P ^c   Van Oosterom, A T ^d  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c EORTC DATA CENTER   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cancer; Chemotherapy; Quality control

Indexed keywords

ARTICLE; HEALTH CARE QUALITY; MEDICAL RECORD; OSTEOSARCOMA; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM; SOFT TISSUE SARCOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; DATA COLLECTION; DOXORUBICIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; MULTICENTER STUDIES; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0030820753     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00027-0     Document Type: Article

References (10)

1. Vantongelen K, Steward W, Blackledge G, Verweij J, van Oosterom AT. EORTC Joint ventures in Quality Control: Treatment-related variables and data acquisition in chemotherapy trials. Eur J Cancer 1991, 27, 201-207.
2. Vantongelen K, Rotmenz N, van der Schueren E. Quality control of validity of data collected in clinical trials. Eur J Cancer 1989, 8, 1241-1247.
3. Frei E II, Canellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med 1980, 69, 585-594.
4. Gehan EA. Dose-response relationship in clinical oncology. Cancer 1984, 54, 1204-1207.
5. White JE, Chen T, McCracken J, et al. the influence of radiation therapy quality control on survival response and sites of relapse in oat cell carcinoma of the lung. Cancer 1982, 50, 1084-1090.
6. Steward WP, Vantongelen K, Verweij J, Thomas D, van Oosterom AT. Chemotherapy Administration and data collection in an EORTC Collaborative Group - can we trust the results? Eur J Cancer 1993, 29A, 943-947.
7. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994, 70, 363-370.
8. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br Med J 1991, 302, 1501-1505.
9. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. Br Med J 1996, 312, 145-148.
10. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995, 345, 1265-1270.